Literature DB >> 12450396

Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization.

Kevin C Wilson1, William W Cruikshank, David M Center, Yujun Zhang.   

Abstract

The immunomodulatory cytokine interleukin-16 (IL-16) represents the secreted C-terminus of a larger precursor, pro-IL-16. Following cleavage by caspase 3, the residual N-terminal domain translocates into the nucleus, inducing G(0)/G(1) cell cycle arrest. We have previously identified a classical bipartite nuclear localization sequence (NLS) in the N-terminal domain of pro-IL-16. We now show that N-terminal to the NLS domain of pro-IL-16 are protein kinase CK2 substrate and cdc2 kinase substrate sites which, along with the NLS, constitute a dual phosphorylation-regulated CcN motif which regulates nuclear localization of pro-IL-16. In addition, we demonstrate that mutation of either site is associated with impairment of the N-terminal domain's ability to induce G(0)/G(1) cell cycle arrest. This is the first description of a functional CcN motif in a cytokine precursor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450396     DOI: 10.1021/bi020163v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.

Authors:  Jian C Qi; Jing Wang; Sravan Mandadi; Kumiko Tanaka; Basil D Roufogalis; Michele C Madigan; Kenneth Lai; Feng Yan; Beng H Chong; Richard L Stevens; Steven A Krilis
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

2.  Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.

Authors:  Clara Curiel-Lewandrowski; Hisato Yamasaki; Chuan Ping Si; Xiaoyi Jin; Yujun Zhang; Jillian Richmond; Marina Tuzova; Kevin Wilson; Beth Sullivan; David Jones; Nataliya Ryzhenko; Frederick Little; Thomas S Kupper; David M Center; William W Cruikshank
Journal:  J Clin Invest       Date:  2011-11-14       Impact factor: 14.808

3.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

4.  High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia.

Authors:  Xinru Wang; Lizhen Li; Yuanjian Wang; Xin Li; Qi Feng; Yu Hou; Chunhong Ma; Chengjiang Gao; Ming Hou; Jun Peng
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

5.  Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES.

Authors:  Gareth Hall; Eilish Cullen; Kovilen Sawmynaden; Joanne Arnold; Simon Fox; Richard Cowan; Frederick W Muskett; David Matthews; Andrew Merritt; Catherine Kettleborough; William Cruikshank; Debra Taylor; Richard Bayliss; Mark D Carr
Journal:  J Biol Chem       Date:  2016-05-26       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.